Ileal bile acid transporter (IBAT)
Assets acting on this target.
- Class
- Ileal bile acid transporter inhibitor
- Notes
- mechanism wave 2026-08-24 (PubMed co-occurrence, 46 article(s)); source: https://pubmed.ncbi.nlm.nih.gov/42421979/
Related mechanisms
Ileal bile acid transporter (IBAT) drugs compared
2 drugs, stage by indication
| Drug | Developer | Modality | Furthest stage | Stage by indication |
|---|---|---|---|---|
| maralixibatLivmarli | Mirum Pharmaceuticals, Inc., Takeda Pharmaceutical Company | small molecule | Approved | Approved in Alagille Syndrome |
| volixibat | Mirum Pharmaceuticals, Inc. | small molecule | Phase 2 | Phase 2 in Primary Biliary Cholangitis; Phase 2 in Primary Sclerosing Cholangitis |